Ormat Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares NYSE:ORA


(MENAFN – GlobeNewsWire – Nasdaq) RENO, Nevada, Nov. 30, 2020 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) (‘Ormat’ or the ‘Company’), a leading vertically integrated company that is primarily engaged in the geothermal and recovered energy generation (‘REG’) businesses, as well the solar photovoltaic (PV) and energy storage and management services business, today announced the full exercise of the underwriters’ option to purchase an additional 622,500 shares of common stock at the public offering price of $74.00 per share in connection with the Company’s previously announced public offering of common stock. After giving effect to the full exercise of the option to purchase additional shares, the total number of shares sold by Ormat in the public offering was 4,772,500 shares resulting in net proceeds of approximately $340 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

‘We are delighted to have successfully completed

Read More

Ormat Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares


The MarketWatch News Department was not involved in the creation of this content.

RENO, Nevada, Nov 30, 2020 (GLOBE NEWSWIRE via COMTEX) —
RENO, Nevada, Nov. 30, 2020 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) (“Ormat” or the “Company”), a leading vertically integrated company that is primarily engaged in the geothermal and recovered energy generation (“REG”) businesses, as well the solar photovoltaic (PV) and energy storage and management services business, today announced the full exercise of the underwriters’ option to purchase an additional 622,500 shares of common stock at the public offering price of $74.00 per share in connection with the Company’s previously announced public offering of common stock. After giving effect to the full exercise of the option to purchase additional shares, the total number of shares sold by Ormat in the public offering was 4,772,500 shares resulting in net proceeds of approximately $340 million, after deducting underwriting

Read More

Ormat Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares


RENO, Nevada, Nov. 30, 2020 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) (“Ormat” or the “Company”), a leading vertically integrated company that is primarily engaged in the geothermal and recovered energy generation (“REG”) businesses, as well the solar photovoltaic (PV) and energy storage and management services business, today announced the full exercise of the underwriters’ option to purchase an additional 622,500 shares of common stock at the public offering price of $74.00 per share in connection with the Company’s previously announced public offering of common stock. After giving effect to the full exercise of the option to purchase additional shares, the total number of shares sold by Ormat in the public offering was 4,772,500 shares resulting in net proceeds of approximately $340 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

“We are delighted to have successfully completed our public offering,” commented Doron

Read More

Arizona reports 4,136 more COVID cases, 36 additional deaths


Read More

Tiga Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Units


SINGAPORE–(BUSINESS WIRE)–Nov 27, 2020–

Tiga Acquisition Corp. (the “Company”) (NYSE: TINV.U) today announced the closing of its initial public offering of 27,600,000 units, which includes 3,600,000 units issued upon the exercise of the underwriters’ overallotment option, which was exercised in full, at a public offering price of $10.00 per unit, resulting in gross proceeds of $276 million. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. The units began trading on the NYSE under the symbol “TINV.U” on November 24, 2020. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on the NYSE under the symbols “TINV” and “TINV WS,” respectively.

The Company is led

Read More

AstraZeneca Says Its Vaccine Needs ‘Additional Study’


The head of British drug manufacturer AstraZeneca said on Thursday further research was needed on its Covid-19 vaccine after questions emerged over the protection it offers, but the additional testing is unlikely to affect regulatory approval in Europe.

AstraZeneca and its partner, the University of Oxford, announced on Monday that it was seeking regulatory approval for the vaccine after it showed an average 70-percent effectiveness.

That rate jumped to 90 percent when an initial half-dose then a full dose was given, similar to that in rival vaccines in development by Pfizer/BioNTech and Moderna.

But US scientists have said the higher rate of effectiveness came during tests in people aged 55 and under, and was discovered by accident during the clinical trials.

The head of the Oxford Vaccine Group, Andrew Pollard, said this week that further evidence will be available next month, but the result was still “highly significant”.

“Now that

Read More

Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares


SAN DIEGO, Nov. 24, 2020 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the closing of its initial public offering of 69,000,000 shares of Class A common stock, including the full exercise of the underwriters’ option to purchase up to 9,000,000 additional shares of Class A common stock, at a public offering price of $27 per share. The aggregate gross proceeds to Maravai from the offering were approximately $1,863,000,000, before deducting underwriting discounts and commissions and other offering expenses. All of the shares in the offering were offered by Maravai. Maravai’s Class A common stock began trading on the Nasdaq Global Select Market on November 20, 2020 under the symbol “MRVI.”

Morgan Stanley, Jefferies and Goldman Sachs & Co. LLC acted as joint book-running managers for the offering. BofA Securities,

Read More

Reed’s Inc. Announces Closing of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares


The MarketWatch News Department was not involved in the creation of this content.

NORWALK, Conn., Nov 24, 2020 (GLOBE NEWSWIRE via COMTEX) —
NORWALK, Conn., Nov. 24, 2020 (GLOBE NEWSWIRE) — Reed’s Inc. (Nasdaq: REED), owner of the nation’s leading portfolio of handcrafted, all-natural beverages, today announced it has closed its previously announced underwritten public offering of 18,750,000 shares and the full exercise of the underwriters’ option to purchase an additional 2,812,500 shares. In total, the Company issued 21,562,500 of its common stock at a price of $0.56 per share for gross proceeds of approximately $12.1 million. Included within the total offering amount, members of Reed’s Board of Directors and senior management invested in the aggregate of approximately $625,000.

“The success of this offering and insider participation is a testament to our collective confidence in our long-term growth potential. We are driving accelerated growth, driven by strong execution and innovation

Read More

Stoke Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares


The MarketWatch News Department was not involved in the creation of this content.

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced the closing of its underwritten public offering of 2,875,000 shares of its common stock, including 375,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares, at a price to the public of $39.00 per share. The net proceeds from the offering were approximately $105.1 million, after deducting underwriting discounts and commissions and estimated offering expenses.

J.P. Morgan Securities LLC, Cowen and Company, LLC, and Credit Suisse Securities (USA) LLC acted as joint book-running managers in the offering. Canaccord Genuity LLC and Cantor Fitzgerald & Co. acted as passive bookrunners in the offering.

Stoke intends to use the net proceeds from the proposed offering, together with its

Read More

Pine Island Acquisition Corp. Announces Partial Exercise and Closing of Underwriters’ Option to Purchase Additional Units in Connection with its Initial Public Offering


FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Pine Island Acquisition Corp. (the “Company”) today announced that the underwriters of its previously announced initial public offering of 20,000,000 units, which closed on November 19, 2020, have partially exercised their option to purchase additional units, resulting in the issuance of an additional 1,838,800 units at a public offering price of $10.00 per unit. After giving effect to the partial exercise and close of the option, an aggregate of 21,838,800 units have been issued in the initial public offering and an aggregate of $218,388,000 has been deposited into the Company’s trust account. The underwriters have until December 31, 2020 to exercise the remainder of their option to purchase additional units.

Each unit consists of one share of the Company’s Class A common stock and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A

Read More